Please ensure Javascript is enabled for purposes of website accessibility

Why GlaxoSmithKline Stock Jumped Today

By Keith Speights - Updated Apr 15, 2021 at 4:26PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

An activist investor is reportedly building a significant position in the drugmaker.

What happened

Shares of GlaxoSmithKline (GSK -0.44%) jumped 4.3% on Thursday. The gain came after The Financial Times reported that activist investor Elliott Management is building a "significant" stake in the drugmaker.

So what

Elliott Management is known for aggressively pushing companies' management teams to make changes that directly benefit shareholders. In recent years, the hedge fund has been instrumental in forcing the boards of companies including Alexion Pharmaceuticals and Alkermes to take different approaches.

conference table and chairs

Image source: Getty Images.

Investors cheered the news that Elliott has its sights set on GlaxoSmithKline. They see the potential involvement of the fund as a positive step that could boost the price of the big pharma stock. The company has underperformed most of its peers, with its share price sinking in recent years.

Now what

It remains to be seen what steps Elliott Management will take with GlaxoSmithKline. The big company plans to soon split its business into two parts: consumer health and pharmaceuticals. The Financial Times reported that some investors would prefer that Glaxo CEO Emma Walmsley run the consumer health business instead of the pharma operations.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

GSK Stock Quote
GSK
GSK
$43.11 (-0.44%) $0.19
Alexion Pharmaceuticals, Inc. Stock Quote
Alexion Pharmaceuticals, Inc.
ALXN
Alkermes plc Stock Quote
Alkermes plc
ALKS
$31.87 (1.40%) $0.44

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
323%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/07/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.